Catherine Ramsey
Stock Analyst at Baird
(3.34)
# 1,256
Out of 4,964 analysts
51
Total ratings
41.94%
Success rate
7.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ILMN Illumina | Maintains: Neutral | $84 → $105 | $99.17 | +5.88% | 6 | Jul 28, 2025 | |
WAT Waters | Maintains: Outperform | $374 → $352 | $297.65 | +18.26% | 11 | Jul 16, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $26.59 | +65.48% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $89.23 | +40.09% | 5 | Apr 29, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $167.88 | +11.98% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $23.46 | +57.72% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $489.74 | +35.79% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $124.96 | +28.04% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $46.95 | +59.74% | 1 | Aug 3, 2022 |
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $99.17
Upside: +5.88%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $297.65
Upside: +18.26%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $26.59
Upside: +65.48%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $89.23
Upside: +40.09%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $167.88
Upside: +11.98%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $23.46
Upside: +57.72%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $489.74
Upside: +35.79%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $124.96
Upside: +28.04%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $46.95
Upside: +59.74%